REGENXBIO INC's ticker is RGNX and the CUSIP is 75901B107. A total of 180 filers reported holding REGENXBIO INC in Q4 2022. The put-call ratio across all filers is 0.88 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $5,655,000 | -70.5% | 213,959 | -72.5% | 0.33% | -79.4% |
| Q2 2022 | $19,183,000 | -5.9% | 776,624 | +26.5% | 1.60% | +3.3% |
| Q1 2022 | $20,381,000 | -38.2% | 614,085 | -39.1% | 1.55% | -19.6% |
| Q4 2021 | $32,964,000 | +516.3% | 1,008,081 | +690.1% | 1.92% | +507.3% |
| Q3 2021 | $5,349,000 | -67.8% | 127,593 | -70.2% | 0.32% | -66.9% |
| Q2 2021 | $16,618,000 | +34.7% | 427,740 | +18.2% | 0.96% | +29.1% |
| Q1 2021 | $12,339,000 | +0.3% | 361,735 | +33.4% | 0.74% | +1.4% |
| Q4 2020 | $12,298,000 | +650.8% | 271,114 | +355.6% | 0.73% | +505.0% |
| Q3 2020 | $1,638,000 | – | 59,507 | – | 0.12% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RTW INVESTMENTS, LP | 1,459,128 | $110,164,000 | 6.60% |
| ArchPoint Investors | 224,187 | $16,926,000 | 4.60% |
| Redmile Group, LLC | 1,656,065 | $125,033,000 | 3.85% |
| WS MANAGEMENT LLLP | 954,812 | $72,088,000 | 2.37% |
| HIGHLINE CAPITAL MANAGEMENT, L.P. | 342,000 | $25,821,000 | 1.19% |
| Perceptive Advisors | 470,672 | $35,536,000 | 0.95% |
| Pier Capital, LLC | 94,492 | $7,134,000 | 0.90% |
| Ipswich Investment Management Co., Inc. | 29,932 | $2,260,000 | 0.76% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 275,000 | $20,763,000 | 0.74% |
| Timpani Capital Management LLC | 27,835 | $2,102,000 | 0.61% |